El interés en corto de Nurix Therapeutics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Nurix Therapeutics. Los datos de interés en corto se actualizan cada dos semanas.

Nurix Therapeutics (NASDAQ:NRIX) Bolsa, Informe de interés en corto

Nurix Therapeutics

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.

Nurix Therapeutics Inc

XXII

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

A New York judge has confirmed the guilty verdict in the hush money case involving President-elect Donald Trump, despite ongoing discussions about presidential immunity.
What Happened: Judge Juan Merchan endorsed the jury&#8217;s decision on Thursday, marking Trump as a felon. This ruling follows Trump&#8217;s recent electoral triumph over Vice President Kamala Harris. The judge has not yet made a decision on Trump&#8217;s request to dismiss the case entirely, given his president-elect status, <a href="https://thehill.com/regulation/court-battles/5043247-trump-hush-money-conviction-uphold/">reported</a> The Hill.
Trump&#8217;s legal team maintained that the evidence presented during his seven-week trial was shielded by the Supreme Court&#8217;s presidential immunity doctrine. This doctrine asserts that former presidents have total&nbsp;immunity from criminal prosecution for&nbsp;exercising core constitutional powers and&nbsp;presumptive immunity for other official&nbsp;acts.
Manhattan District Attorney&nbsp;Alvin Bragg&nbsp;refuted these claims, stating that no evidence presented to the jury was protected. He further contended that&nbsp;even if it was, it&nbsp;was inconsequential compared to the &#8220;overwhelming evidence of defendant&#8217;s guilt.&#8221;
Trump was found guilty on 34 counts of falsifying business records related to a $130,000 hush money payment to adult film actress Stormy Daniels before the 2016 presidential election. Prosecutors portrayed this as an attempt to unlawfully influence the election&#8217;s outcome.
The judge&#8217;s decision on whether to halt the proceedings during Trump&#8217;s term is still pending. Meanwhile, Trump&#8217;s other criminal proceedings have not been as successful following his presidential win.
See Also: <a href="https://www.benzinga.com/politics/24/12/42511472/trump-hits-7-year-high-in-favorability-ratings-how-republicans-democrats-men-and-women-view-president-elect?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Trump Hits 7-Year High In Favorability Ratings: How Republicans, Democrats, Men And Women View President-Elect</a>
Why It Matters: The Supreme Court had <a href="https://www.benzinga.com/general/politics/24/07/39577351/trump-granted-partial-immunity-by-supreme-court-ruling-says-the-president-is-not-above-the-law-d">previously ruled</a> that Trump and former presidents are entitled to immunity for acts within their Constitutional authority while in office, but not unofficial acts.
Trump&#8217;s <a href="https://www.benzinga.com/news/24/09/40699789/judge-rejects-trumps-attempt-to-move-hush-money-trial-to-federal-court-citing-lack-of-good-cause">attempt to move</a> his hush money criminal case to federal court was denied due to a lack of &#8220;good cause&#8221;, according to a previous report. The <a href="https://www.benzinga.com/general/politics/24/09/40754802/trump-hush-money-sentencing-will-now-take-place-after-2024-election-to-avoid-any-appearance-to-a">sentencing</a> for Trump&#8217;s hush money trial was postponed until after the 2024 presidential election to avoid any potential influence on the election. 
Image via Shutterstock
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

News

Politics

General

Trump's Hush Money Conviction Upheld Amid Presidential Immunity Controversy — Alvin Bragg Says 'Overwhelming' Evidence Of Guilt

Billionaire Elon Musk has watched his wealth soar this year, especially after the 2024 presidential election, thanks to soaring valuations for SpaceX and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), two companies that could benefit from the next <a href="https://www.benzinga.com/news/management/24/12/42444955/elon-musk-first-person-worth-400-billion-as-tesla-stock-hits-new-all-time-highs-how-2024-election-helped-could-lead-to-future-gains">White House administration.</a>
What Happened: Musk added $226 billion to his wealth in 2024, with the majority of gains happening after Donald Trump won <a href="https://www.benzinga.com/markets/equities/24/11/41813356/elon-musks-net-worth-soars-by-26-5-billion-in-single-day-after-tesla-stock-surges-post-trump-vic">the 2024 election.</a>
Musk endorsed Trump in the 2024 election, donated to his campaign, and even campaigned for him in the key swing state of Pennsylvania. The efforts paid off for Musk's wealth, which stands at $455 billion at the time of writing, as reported by <a href="https://www.bloomberg.com/billionaires/">Bloomberg</a>.
With Musk reaching the historic $400 billion wealth milestone, he has more money than the valuation of every single Major League Baseball, National Basketball Association, National Football League and National Hockey League team combined.
Forbes shows the New York Yankees as the highest-valued <a href="https://www.forbes.com/lists/mlb-valuations/">MLB </a>team at $7.55 billion and the average team worth $2.4 billion.
<a href="https://www.forbes.com/sites/justinteitelbaum/2024/10/24/the-most-valuable-nba-teams-2024/">NBA </a>teams have an average value of $4.4 billion, led by the Golden State Warriors at $8.8 billion and every team worth at least $3 billion. The New York Knicks, which are owned by publicly traded Madison Square Garden Sports Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>), rank second with a valuation of $7.5 billion, as reported by Forbes.
The <a href="https://www.forbes.com/sites/justinteitelbaum/2024/08/29/the-nfls-most-valuable-teams-2024/">NFL </a>teams have the highest valuation with the Dallas Cowboys ranking first at $10.1 billion, the first team valued at more than $10 billion. The lowest team is worth $4.1 billion and the average sits at $5.7 billion.
<a href="https://www.forbes.com/lists/nhl-valuations/">NHL </a>teams rank last of the four major North American sports leagues with an average team valuation of $1.33 billion. The highest-ranked team is the Toronto Maple Leafs valued at $2.8 billion and the lowest team ranked at $500 million. The New York Rangers, who are also owned by Madison Square Garden Sports, rank second at $2.65 billion.
Here are the total amounts across the leagues:
<ul>
<li>MLB: $73.66 billion</li>
<li>NBA: $135.50 billion</li>
<li>NFL: $181.95 billion</li>
<li>NHL: $42.46 billion</li>
<li>Total: $433.57 billion</li>
</ul>
Based on the current team valuations of the teams, Musk could buy all the teams for $433.57 billion and still have $21.43 billion left over.
You may not be a billionaire like Mark Cuban, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/general/social-media/24/12/42490690/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">check out five stocks flying under the radar that deserve your attention.</a>
Why It's Important: This valuation exercise is of course hypothetical as no one can own multiple teams in any sport and there are also rules in place across some leagues for ownership of teams in other leagues.
That means Tesla shareholders can breathe a sigh of relief. While Musk is worth $455 billion, the majority of his wealth comes from ownership stakes in the companies he leads, including SpaceX and Tesla.
To fund a <a href="https://www.benzinga.com/news/23/04/31810229/elon-musk-bought-twitter-1-year-ago-a-look-back-at-whats-happened-since-and-what-could-be-next">$44 billion buyout </a>of Twitter, which is now known as X, Musk had to sell portions of his Tesla stock. The move, known to analysts and investors as the Twitter overhang, led to Tesla shares trading down as worries of more sales continued to beat shares down during the buyout process.
Musk also has not expressed interest in owning a sports team in MLB, NBA, NFL or the NHL over the years. The world's richest man<a href="https://www.benzinga.com/news/23/02/30909752/wait-is-elon-musk-considering-a-manchester-united-bid-after-all"> did joke about buying</a> publicly traded soccer team Manchester United (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANU#NYSE">MANU</a>) previously, but nothing came of the comments.
Billionaires have bought sports teams over the years. Others have become billionaires thanks to their ownership of professional sports teams. Amazon founder Jeff Bezos has been <a href="https://www.benzinga.com/general/sports/24/08/40607642/jeff-bezos-could-have-competition-if-he-wants-the-nfls-seattle-seahawks-private-equity-investments">reported to have an interest </a>in owning an NFL team in the future.
Sports teams have seen values rise over the years thanks to increased ticket prices, advertising opportunities and huge media rights deals.
While Musk&#8217;s wealth is already up significantly in 2024, it could increase further in the coming years. Musk could benefit from the new White House administration, which could eliminate EV tax credits that would hurt Tesla competitors.
There is also optimism that the new administration&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42046316/trump-set-to-hand-musk-golden-path-for-tesla-after-reversing-course-on-autonomous-vehicle-ban" target="_blank" rel="noreferrer noopener">could support regulation</a>&nbsp;for self-driving vehicles such as the Tesla robotaxi, reversing course on Trump&#8217;s<a href="https://www.benzinga.com/general/politics/24/10/41298125/maybe-musk-missed-the-memo-trumps-plan-to-ban-autonomous-vehicles-could-sour-friendship" target="_blank" rel="noreferrer noopener">&nbsp;previous plan to ban&nbsp;</a>autonomous vehicles.
One item that could dent Musk&#8217;s wealth is the pending case against his 2018 Tesla pay compensation plan. A Delaware judge&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42279851/elon-musk-56b-pay-package-rejected-by-judge-again-tesla-analyst-says-a-soap-opera-playing-out-in-delaware" target="_blank" rel="noreferrer noopener">struck down the plan again</a>, despite shareholder approval, but Tesla said it will appeal the decision. Without the pay package, Musk would still be the world&#8217;s richest person, but not at such a high level.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42472121/miami-dolphins-nfl-fans-can-own-part-of-team-thanks-to-this-public-company">Miami Dolphins, NFL Fans Can Own Part Of Team Thanks To This Public Company</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Photos: Shutterstock

Sports

Management

MANU

MSGS

TSLA

Elon Musk Is So Rich He Could Buy Every MLB, NBA, NFL, NHL Team And Still Have Cash Left Over

University of Colorado football star Travis Hunter took home the Heisman Trophy Saturday night, adding to his rare pathway to the NFL that included turning down Division I schools to play for Deion Sanders at <a href="https://www.benzinga.com/news/21/12/24631543/how-deion-sanders-and-the-nations-top-high-school-recruit-are-shaking-up-college-football">Football Championship Subdivision school Jackson State University.</a>
What Happened: With Hunter a Heisman Trophy winner and a rare two-way threat playing both cornerback and wide receiver, attention will now shift to how high he could get drafted in the 2025 NFL Draft and if he can break a<a href="https://www.benzinga.com/general/sports-betting/24/04/38501129/2024-nfl-draft-recap-quarterbacks-wide-receivers-detroit-set-records-who-will-win-rookie-o"> recent string of preference</a> to take quarterbacks first overall.
In the 2024 NFL Draft, six quarterbacks were selected in the first round setting records for the position. Among the draft picks were quarterbacks Caleb Williams and Jayden Daniels at first and second overall, who won the Heisman Trophy in 2022 and 2023, respectively.
Here are the most recent Heisman Trophy winners and their NFL Draft positions:
<ul>
<li>2023: Jayden Daniels, Quarterback, 2nd overall</li>
<li>2022: Caleb Williams, Quarterback, 1st overall</li>
<li>2021: Bryce Young, Quarterback, 1st overall</li>
<li>2020: DeVonta Smith, Wide receiver: 10th overall</li>
<li>2019: Joe Burrow, Quarterback, 1st overall</li>
<li>2018: Kyler Murray, Quarterback, 1st overall</li>
<li>2017: Baker Mayfield, Quarterback, 1st overall</li>
<li>2016: Lamar Jackson, Quarterback, 32nd overall</li>
<li>2015: Derrick Henry, Running back, 45th overall</li>
<li>2014: Marcus Mariota, Quarterback, 2nd overall</li>
<li>2013: Jameis Winston, Quarterback, 1st overall</li>
</ul>
The list shows the Heisman Trophy is often won by a quarterback with the position taking home the honors in nine of the past 11 years. In the past 11 years, six of the Heisman Trophy winners have gone first overall in a future NFL Draft.
No non-quarterback Heisman Trophy winner has gone first overall in the NFL Draft since running back Bo Jackson in 1985, according to the <a href="https://www.ncaa.com/news/football/article/2024-04-25/every-heisman-winner-be-selected-no-1-overall-nfl-draft">NCAA</a>. Of the 25 Heisman Trophy winners who have gone first overall, all have been listed as a quarterback, running back or tight end. 
Also keep in mind that the last time a wide receiver went first overall was 1996 and the last time a defensive back went first overall was 1956, with a preference for quarterbacks, defensive ends and offensive linemen in recent years.
Hunter as a wide receiver and cornerback would set some new firsts if he goes first overall. This could be why he's the current second favorite on sportsbook DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) to go first overall at odds of +350. Listed ahead of Hunter is his teammate, Colorado quarterback Shedeur Sanders at odds of -120.
Trailing the two Colorado teammates is Miami quarterback Cam Ward, who was also a Heisman Trophy finalist, at odds of +400. No other player has odds lower than +2500. This means these three are the high favorites of going first overall, but right now it could be anyone's game of who will go first overall and likely will depend on which team secures the first overall pick.
Read Also: <a href="https://www.benzinga.com/general/gaming/24/02/37292071/game-on-or-sellout-this-is-how-much-ea-sports-offers-college-football-players-for-their-likeness" target="_blank" rel="noreferrer noopener">Game On Or Sellout? This Is How Much EA Sports Offers College Football Players For Their Likeness</a>
What's Next: One of the big questions for whoever drafts Hunter will be which position they want him to play in the NFL or if he will play both. During this season, Hunter <a href="https://x.com/PFF_College/status/1866945539801223417">had </a>709 offensive snaps and 713 defensive snaps, averaging 118 per game, significantly higher than anyone else in NCAA Football Division I.
Fox Sports analyst Jay Glazer <a href="https://x.com/JayGlazer/status/1868731686932078974">said </a>Sunday that he polled 13 NFL coaches and GMs asking about Hunter, with 12 saying they would play the Heisman winner primarily at CB with some offensive packages. The lone person who said wide receiver said the elite ball skills made the position the one Hunter should play. The 12 who picked cornerback also acknowledged elite ball skills and said a shutdown cornerback is harder to find.
The 2025 NFL Draft will be held in Green Bay, Wisconsin, with the first round happening on April 24 with Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) airing coverage on ABC and ESPN.
Colorado takes on Brigham Young University in the Alamo Bowl on Dec. 28 at 7:30 p.m. in a game that will air on ABC. Hunter indicated Monday that he plans to play in the game. Some players leaving for college sit out bowl games. This would mean NFL scouts, coaches and general managers could get another look at the rare two-way star ahead of the NFL Draft.
Hunter going high in the NFL Draft and succeeding at the next level could be big for Adidas AG &#8211; ADR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ADDYY#OTC">ADDYY</a>), which <a href="https://news.adidas.com/american-football/adidas-welcomes-collegiate-superstar-travis-hunter-to-the-three-stripes--expanding-its-next-gen-athl/s/a02057f4-e796-426e-84c7-ac2ae40dfc66">signed </a>the NCAA star to its growing roster of NFL players.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/23/05/32532826/tim-tebow-turned-down-1-million-commercial-for-a-1-chance-to-play-in-nfl-a-lesson-in-passion-and-sac">Tim Tebow Turned Down $1 Million Commercial For A 1% Chance To Play In NFL: A Lesson In Passion And Sacrifice</a></li>
</ul>
Photo: Debby Wong via Shutterstock

Entertainment

Sports Betting

ADDYY

DKNG

Travis Hunter Wins Heisman, Will He Be #1 Pick In 2025 NFL Draft? What Betting Odds, History Show

Amphenol (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) has outperformed the market over the past 15 years by 7.01% on an annualized basis producing an average annual return of 18.95%. Currently, Amphenol has a market capitalization of $91.20 billion. 
Buying $100 In APH: If an investor had bought $100 of APH stock 15 years ago, it would be worth $1,375.94 today based on a price of $75.65 for APH at the time of writing.
<h3>Amphenol's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734392709_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Amphenol 15 Years Ago Would Be Worth Today

Jeff Bezos, owner of the Washington Post and founder of Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), told a group at The New York Times DealBook Summit in early December that he likes meetings to be "messy" so that he can be part of the "sausage-making" process. 
The Details: Bezos, well-known as the world's second richest person, is also notable for his strong opinions on how business meetings should be run. 
Bezos discouraged PowerPoint presentations at Amazon's <a href="https://www.benzinga.com/general/education/24/09/41107170/jeff-bezos-used-this-method-to-get-true-opinions-from-employees-amazon-founder-says-youre-the-b">internal meetings</a> and set standards for meetings to seek the truth rather than to appeal or please the executives. 
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42515463/nike-needs-a-turnaround-after-q2-results-are-released-this-week-will-new-ceo-just-do-it">Nike Needs A Turnaround After Q2 Results Are Released This Week: Will New CEO &#8216;Just Do It?&#8217;</a>
&#8220;You don&#8217;t want the whole thing to be figured out and presented to you,&#8221; he said, according to a Business Insider <a href="https://www.businessinsider.com/jeff-bezos-messy-meetings-amazon-founder-achieve-more-2024-12">report</a>.&nbsp;
Bezos likes to begin meetings with a 30-minute window for participants to read through a detailed memo that outlines the background information and then open a "messy" discussion.&nbsp;
&#8220;I like the memos to be like angels singing from on high, so clear and beautiful, and then the meeting can be messy," he told The New York Times.&nbsp;
&#8220;Show me the ugly bits. I always ask, are there any dissenting opinions on the team? I want to try to get to the controversy,&#8221; Bezos said.
More Of Bezos' Style: Lauren Sanchez, Bezos' girlfriend, told the Wall Street Journal that he advised her not to be the first to speak in a meeting.&nbsp;
"No, no, no. You&#8217;re the boss. You talk last. You let everyone else talk, so that they don&#8217;t get swayed by your opinion,&#8221; Sánchez shared in the interview.
The Amazon founder is also known for his "Two Pizza Rule" which states that meetings should have no more participants than can be fed with two large pizzas.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42440681/markets-have-the-green-light-to-rally-after-novembers-yawner-inflation-report-experts-say">&#8216;Markets Have The Green Light To Rally&#8217; After November&#8217;s &#8216;Yawner&#8217; Inflation Report, Experts Say</a></li>
</ul>
Phot: Shutterstock

Large Cap

Psychology

Movers

Tech

AMZN

Jeff Bezos Prefers 'Messy' Meetings, Be Part Of The 'Sausage-Making' Process

Dynatrace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DT#NYSE">DT</a>) has outperformed the market over the past 5 years by 2.91% on an annualized basis producing an average annual return of 16.51%. Currently, Dynatrace has a market capitalization of $16.35 billion. 
Buying $100 In DT: If an investor had bought $100 of DT stock 5 years ago, it would be worth $221.46 today based on a price of $54.79 for DT at the time of writing.
<h3>Dynatrace's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734391807_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Dynatrace 5 Years Ago Would Be Worth Today

Canadian Finance Minister Chrystia Freeland resigned Monday, citing disagreements with Prime Minister Justin Trudeau over <a href="https://www.benzinga.com/news/global/24/12/42475000/if-trump-starts-a-trade-war-canada-could-impose-export-taxes-on-oil-uranium-report">anticipated U.S. tariffs.</a>
What Happened? Freeland, who also held the position of Deputy Prime Minister, resigned hours before she was due to deliver an economic update to the parliament. In a letter to Trudeau, Freeland <a href="https://x.com/cafreeland/status/1868659332285702167">noted</a> she made this decision after his suggestion to take a different position within his Cabinet.
She also reflected on President-elect Donald Trump's proposed 25% tariffs.
"We need to take that threat extremely seriously. That means keeping our fiscal powder dry today, so we have the reserves we may need for a coming tariff war," she wrote.
Freeland, a veteran journalist and a key member of Trudeau's cabinet since 2015 has held multiple high-profile roles, including Minister of Foreign Affairs. Interestingly, her predecessor, Bill Morneau, resigned over a fallout with Trudeau in 2020 as they clashed over issues with COVID-19-related income support programs.
Meanwhile, Housing Minister Sean Fraser will not seek re-election in Nova Scotia and will leave the federal cabinet during the next shuffle, <a href="https://www.cbc.ca/player/play/video/9.6593309">per</a> CBC News. The shuffle, which could happen as early as Wednesday, could see former Bank of Canada and Bank of England governor Mark Carney joining the cabinet.&nbsp;
Why It Matters? Freeland's departure signals further weakening of Trudeau's government ahead of the election year.
As a widely respected figure, she was critical in securing Canada's trade interests and the architect of Canada's response to the U.S.-Mexico-Canada Agreement renegotiation during Trump's first term. With Freeland's exit, Trudeau loses a highly skilled negotiator at a pivotal time in international trade relations and domestic economic challenges.
Trudeau maintains the stance that imposing tariffs would hurt both sides.
"Let's not kid ourselves in any way, shape or form, 25% tariffs on everything going to the United States would be devastating for the Canadian economy," Trudeau said <a href="https://apnews.com/article/canada-trudeau-us-trump-tariffs-f23417b8f6671adf6b4c908be630615f">per</a> AP News, clarifying how tariffs on Canadian energy and various commodity exports would make life more expensive in the U.S.
Between November 2023 and October 2024, Canada exported over C$172 billion ($120.74 billion) worth of energy products to the U.S. and C$80.4 billion ($56.44 billion) worth of motor vehicles and parts. Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) have notable operations in Canada, as do foreign manufacturers like Fiat Chrysler Automobiles, Honda, and Toyota.
The internal crisis has driven down the Liberal Party's popularity. Polls <a href="https://newsinteractives.cbc.ca/elections/poll-tracker/canada/">show</a> Trudeau's government trails significantly behind the Conservative Party, with the next federal election due by October 2025.
Market Reaction: USD/CAD rose 0.11% for the day, closing the trading session at 1.4241. Since Donald Trump&#8217;s re-election, the pair rose around 3%.
Read Next: • <a href="https://www.benzinga.com/news/global/24/12/42513807/trump-says-softbanks-100b-commitment-to-us-is-monumental-demonstration-of-confidence-in-americas-future">Trump Says SoftBank&#8217;s $100B Commitment To US Is &#8216;Monumental Demonstration Of Confidence In America&#8217;s Future&#8217;</a>
Photo: Photocosmos1 via Shutterstock

Government

Commodities

Global

Trudeau's Government Loses A Top Negotiator Ahead Of Trump's Second Term

GoDaddy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDDY#NYSE">GDDY</a>) has outperformed the market over the past 5 years by 11.24% on an annualized basis producing an average annual return of 24.84%. Currently, GoDaddy has a market capitalization of $29.35 billion. 
Buying $100 In GDDY: If an investor had bought $100 of GDDY stock 5 years ago, it would be worth $305.24 today based on a price of $209.03 for GDDY at the time of writing.
<h3>GoDaddy's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734390909_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GDDY

Here's How Much $100 Invested In GoDaddy 5 Years Ago Would Be Worth Today

Super Micro Computer, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) stock is trading below its 50-day moving average as it awaits removal from the Nasdaq 100 Index on <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42494812/annual-changes-to-the-nasdaq-100-index" rel="noreferrer noopener">December 23, 2024</a>, joining the likes of Illumina, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>)&nbsp;and&nbsp;Moderna, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>).
Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), MicroStrategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), and Axon Enterprise Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) entered the coveted club as a replacement.
The Nasdaq-100 Index comprises 100 of the largest non-financial companies on The Nasdaq Stock Market.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42514598/hubspots-ai-powered-tools-set-to-drive-smb-growth-and-crm-innovation-analyst-says" rel="noreferrer noopener">HubSpot To Dominate SMB CRM Space With AI-Driven Platform, Says BofA Analyst</a>
Established in January 1985 alongside the Nasdaq Financial-100 Index, which tracks the 100 largest financial stocks on Nasdaq, these indexes serve as benchmarks for financial instruments like options, futures, and funds.
The Nasdaq-100 undergoes an annual reconstitution each December, aligned with the quadruple witching expiration on Friday of the quarter.
Super Micro Computer stock plunged 62% in the last six months. Reportedly, the AI server company has <a target="_blank" href="https://www.benzinga.com/news/financing/24/12/42506690/super-micro-seeks-to-raise-capital-via-equity-and-debt" rel="noreferrer noopener">enlisted Evercore to</a> assist in raising capital.
The effort aims to avoid a potential delisting after the company missed its August deadline for filing its annual financial report while reviewing internal financial controls.
The company is considering private investment in public equity (PIPE) funding, which could attract interest from private equity firms. While PIPE funding provides a faster capital-raising method, it dilutes existing shareholders&#8217; equity.
Concerns still need to be made about the profitability of Super Micro&#8217;s AI-optimized servers due to reliance on high-end chips from suppliers like Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
Super Micro&#8217;s auditor, Ernst &amp; Young, resigned in October over governance concerns. This led to a sharp decline in stock value and prompted an independent committee to investigate. By December, the committee found no evidence of misconduct, spurring a 30% rise in Super Micro&#8217;s stock.
The company appointed BDO USA as its new auditor to address delisting risks, submitted a compliance plan to Nasdaq, and began searching for a new finance chief based on the committee&#8217;s recommendations.
Super Micro, which faced scrutiny from a Hindenburg Research report and a U.S. Department of Justice probe, has until February 25 to file its delayed financial reports.
Super Micro Computer missed the revenue estimates for the last two quarters and the adjusted EPS consensus for the last quarter.
In July 2024, Super Micro Computer <a target="_blank" href="https://www.benzinga.com/news/24/07/39847680/whats-going-on-with-super-micro-computer-shares-today" rel="noreferrer noopener">became a component</a> of the Nasdaq-100 Index and the Nasdaq-100 Equal Weighted Index, replacing Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>).
At that time, CEO Charles Liang highlighted Super Micro&#8217;s eco-friendly initiatives and AI growth opportunities during an interview with CNBC&#8217;s Jim Cramer.
Liang showcased the potential of their &#8220;liquid cooling&#8221; and &#8220;green computer&#8221; technologies to cut carbon emissions and reduce customer expenses.
He also shared his confidence in the transformative power of AI, predicting it could have a more significant impact than the industrial revolution.
The Nasdaq-100 Index underpins the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which seeks to deliver investment results mirroring the index&#8217;s performance before expenses.
Price Action: SMCI stock closed lower by 8.26% to $33.44 on Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42514450/grindrs-expanding-lgbtq-market-and-20-revenue-growth-impresses-goldman-sachs" target="_blank" rel="noreferrer noopener">Grindr&#8217;s Expanding LGBTQ+ Market and 20% Revenue Growth Impresses Goldman Sachs</a></li>
</ul>
Photo via Company

AXON

ILMN

MRNA

MSTR

NVDA

PLTR

SMCI

Super Micro Drops Below 50-Day Average, Faces Nasdaq 100 Removal Just Months After Entry

Toll Brothers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) has outperformed the market over the past 5 years by 13.88% on an annualized basis producing an average annual return of 27.48%. Currently, Toll Brothers has a market capitalization of $13.58 billion. 
Buying $1000 In TOL: If an investor had bought $1000 of TOL stock 5 years ago, it would be worth $3,449.88 today based on a price of $134.58 for TOL at the time of writing.
<h3>Toll Brothers's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734390009_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Toll Brothers Stock In The Last 5 Years

CMTG paid three regular quarterly dividends during the year totaling $0.60 per share of common stock, which exceeds its 2024 taxable income estimate.
"Looking ahead, the Board of Directors will determine whether to reinstate the quarterly dividend based on broader market conditions, the Company's financial performance and estimated REIT taxable income."

Dividends

CMTG

Claros Mortgage Trust Board Suspends Quarterly Dividend On Its Common Stock Commencing With Q4 Dividend That Would Have Otherwise Been Paid In January 2025

TSLA CLOSES AT THE HIGH OF THE DAY UP OVER 16 POINTS AFTER ALERT
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="700" height="624" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/16212216/Screen-Shot-2024-12-16-at-4.22.24-PM.png" alt="" class="wp-image-4149" style="width:920px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/16212216/Screen-Shot-2024-12-16-at-4.22.24-PM.png 700w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/12/16212216/Screen-Shot-2024-12-16-at-4.22.24-PM-300x267.png 300w" sizes="(max-width: 700px) 100vw, 700px" /></figure>
Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:32 AM on December 16th, a significant trading signal occurred for Tesla , Inc. (TSLA) as it demonstrated a Power Inflow at a price of $445.52. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Tesla&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Tesla&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted by active traders as a bullish signal.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for TSLA, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like&nbsp; &nbsp; <a href="https://www.tradepulse.net">https://www.tradepulse.net</a>&nbsp; which are responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:
The price at the time of the Power Inflow was $445.52. The returns on the High price ($462) and Close price ($462) after the Power Inflow were respectively 3.7% and 3.7%%. That is why it is important to have a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. In this case, the high of the day and close were the same but that is not always the case
Past Performance is Not Indicative of Future Results

TradePulse Power Inflow Alert: Tesla Inc. (TSLA) Receives Alert And Climbs 3.6% On The Day

Amid the uncertainty, one thing seems clear: <a href="https://www.benzinga.com/government/regulations/24/11/42120607/gary-gensler-to-step-down-as-sec-chair-on-trumps-inauguration-day">SEC chair Gary Gensler is set to step down</a>, and institutional investors are already anticipating a new regulatory landscape for US markets.&nbsp;
Trump had previously promised at the Bitcoin 2024 conference in July that he <a href="https://www.thebanker.com/Explainer-Why-the-Trump-card-cannot-be-pulled-on-Gary-Gensler-1732190555" target="_blank" rel="noreferrer noopener nofollow">would fire Gensler</a> on day one of his return to the White House, but it appears that the chair plans to step down from his role on January 20, 2025, the day of the President-election inauguration. 
Gensler's departure will change Wall Street's regulatory landscape, and on the surface, it appears that a more focused move towards deregulation and an end to Gensler's famous cryptocurrency skepticism. But how can institutions prepare for the changes that next year will bring? Let's take a deeper look at the state of play for US markets moving into Trump's second term: 
<h2 class="wp-block-heading">Regulatory Climbdown</h2>
One key adaptation that institutional investors will need to make is preparing for a deregulated Wall Street.&nbsp;
The regulatory climate in the US had been more expansive in the wake of the 2008 financial crisis, with Congress expanding the US government's oversight of the financial industry to safeguard against future collapses.&nbsp;
But it appears likely that Trump's second term will see efforts to scale back these reforms take place, with significant ramifications for the investment landscape.&nbsp;
According to Reuters sources, one potential act of deregulation could see a curtailing of the Dodd-Frank Act, which was implemented in the wake of the financial crash with the intention of reducing systemic risk. Other ideas are focused on making it easier for private companies to raise capital, potentially opening up access to more challenging private funds and securities. 
The prospect of deregulation comes in <a href="https://www.politico.com/live-updates/2024/11/27/congress/former-sec-official-eyed-for-chair-00191952" target="_blank" rel="noreferrer noopener nofollow">direct contrast to Gensler's time</a> as the chair of the SEC, which sparked controversy within the financial industry and cryptocurrency lobby. 
While there are certainly high-profile cases of collapses within the financial industry, fintech space, and cryptocurrency landscape, Wall Street appears to welcome the change of pace and more growth-focused approach.&nbsp;
<h2 class="wp-block-heading">Is a Wall Street Rally Imminent?</h2>
Interestingly, Wall Street's positive reception to Gary Gensler's departure appears bullish even despite the dangers of deregulation and the prospect of Trump's tariffs hampering growth in the financial sector.&nbsp;
According to Jenny Grimberg, executive director of global macro research at Goldman Sachs, anticipated <a href="https://seekingalpha.com/news/4271783-wall-street-economists-see-risks-from-trump-tariffs-rewards-from-deregulation" target="_blank" rel="noreferrer noopener nofollow">average 20 percentage point tariffs</a> on imports from China would likely provide modest boosts to US inflation while lowering growth in the United States. 
Despite this, Goldman Sachs anticipates that the S&amp;P 500 will still rise by around 5% over the course of the year ahead.&nbsp;
Even when facing the prospect of higher inflation and higher interest rates, Wall Street has still adopted a <a href="https://www.reuters.com/markets/us/wall-street-girds-trump-20-tariffs-tax-cuts-volatility-2024-11-06/" target="_blank" rel="noreferrer noopener nofollow">pro-growth outlook</a> for the Trump administration, according to David Bianco, Americas CIO at DWS Group. 
<h2 class="wp-block-heading">Which Investment Opportunities Will Prosper?&nbsp;</h2>
Gary Gensler had continuously <a href="https://www.ccn.com/news/crypto/sec-chair-gary-gensler-top-crypto-crackdowns/">pursued lawsuits</a> throughout the crypto sector during his time as chair, targeting projects like Ripple, and exchanges such as Binance, Coinbase, FTX, and Kraken.&nbsp;
While the case against FTX and owner Sam Bankman-Fried underlined the importance of regulation in the wake of the exchange's collapse in 2022, Gensler has long been identified as an obstructive force by cryptocurrency enthusiasts.&nbsp;
Trump's election victory prompted a widespread cryptocurrency market rally that's underlined the underlined the expectation that Trump will bring a more conducive environment for cryptocurrency investing on Wall Street.&nbsp;
As a result, we're likely to see more institutional investors ramp up their crypto exposure in the wake of Gensler's time as chair.&nbsp;
Institutions can also find value among other asset managers in this new pro-growth, deregulated environment, and Berkshire Hathaway's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) exposure to US infrastructure might <a href="https://www.fool.co.uk/2024/12/02/3-sp-500-stocks-that-could-surge-under-donald-trump-as-us-president/" target="_blank" rel="noreferrer noopener nofollow">help the conglomerate to prosper</a> off the back of the Trump Presidency. 
<h2 class="wp-block-heading">Uncertainty Lingers</h2>
With the prospect of steep tariffs impacting US trade in the near future, diversification will be a major consideration for institutional investors seeking to manage their exposure to risk in the era of a newly-reformed SEC.&nbsp;
This is likely to push more hedge funds and other institutions towards international investments, particularly as China ramps up its stimulus plan to overcome its own <a href="https://www.26degreesglobalmarkets.com/market-impact-its-importance-and-how-to-manage-it/">market impact</a>.&nbsp;
Institutional investors should explore a prime broker solution's catalog of globally focused market access tools to ensure that their risk is appropriately hedged as a new chair with a looser strategy rings the changes throughout the investment landscape.&nbsp;
<h2 class="wp-block-heading">Is Wall Street Right to Anticipate Growth?&nbsp;</h2>
The appointment of Elon Musk to the newly formed <a href="https://www.benzinga.com/24/11/42253427/elon-musks-doge-dream-team-from-marc-andreessen-to-ubers-travis-kalanick-silicon-valley-titans-join-forces-to-overhaul-federal-spending">Department of Government Efficiency</a>, a name that carries a knowing nod to cryptocurrency Dogecoin, takes us into uncharted territory in terms of the future of regulation on the financial sector.&nbsp;
With the CEO of a company worth more than $1 trillion in market capitalization taking a key role in the new government, we're likely to see concerted efforts made to clear the way for further pro-growth strategies among some of the United States' largest market players.&nbsp;
However, with the prospect of tariffs looming large over markets, all bets are off regarding what the future holds for Wall Street and institutional investors.
On the date of publication, Dmytro Spilka did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer. Dmytro Spilka does not intend to make a trade in any of the securities mentioned above in the next 72 hours.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Fintech news covering the emerging Financial Technology services sector

Fintech

How Can Institutional Investors Prepare for Life After Gary Gensler Leaves the SEC?

Two of the globe&#8217;s largest chip manufacturers will clash in court this week due to a <a href="https://www.benzinga.com/topic/intellectual-property">disagreement over intellectual property</a>.
What Happened: Arm Holdings plc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) legal spat with Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) commenced Monday, Dec. 16, before a federal jury in Delaware, Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-12-16/arm-qualcomm-contract-fight-threatens-to-upend-chip-industry?sref=TBDibEcD">reported</a>.
Recall Qualcomm's <a href="https://www.benzinga.com/government/21/01/19148004/qualcomm-to-buy-startup-nuvia-in-1-4b-deal-what-investors-need-to-know">$1.4 billion acquisition of NUVIA</a>, a chip startup, in 2021. Just two years earlier, Arm granted licenses to NUVIA — assets Qualcomm eventually inherited.
Arm, headquartered in the U.K. and majority-owned by SoftBank Group, claims the Nuvia deal requires renegotiation. It also wants Qualcomm to destroy certain chip designs it received once the deal closed.
Qualcomm, in court documents, insists it has its own license agreements with Arm. &#8220;Qualcomm has licensed and paid for the same intellectual property that NUVIA licensed under its own separate agreements with ARM,&#8221; the statement <a href="https://semianalysis.com/wp-content/uploads/files/71776a9c-ee79-4c5c-947b-f7e98cf40bcc.pdf">reads</a>. 
<h1 class="wp-block-heading">ETFs To Watch</h1>
As per <a href="https://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>, chip ETFs closed in the green Monday:
<ul>
<li>VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>) was up 0.56%</li>
<li>Invesco PHLX Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXQ#NASDAQ">SOXQ</a>) was up 0.49%</li>
<li>Columbia Semiconductor and Technology ET (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMI#NYSE">SEMI</a>) was up 2.75%</li>
<li>Direxion Daily Semiconductor Bull 3X Shares ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXL#NYSE">SOXL</a>) was up 5.88%</li>
</ul>
Why It Matters: The case — Arm v. Qualcomm, 22-cv-01146, US District Court, District of Delaware (Wilmington) — will likely see both CEOs, Arm&#8217;s Rene Haas and Qualcomm&#8217;s Cristiano Amon, take the stand.
This isn't the first time an M&amp;A agreement involving these companies sparked legal challenges. Back in 2020, Nvidia attempted to buy Arm for $40 billion, which threw San Diego-based Qualcomm and other tech companies into a panic.
Regulators sank the deal in 2022 when the Federal Trade Commission sued Nvidia to block the merger. Arm also faced substantial regulatory pressure from British authorities.&nbsp;
Fast-forward to today, and Arm is now trying to flex its muscles by pulling Qualcomm's license — worth an estimated $1.5 billion.
And Qualcomm is not known to give up easily. Recall its past licensing tussle with Apple, <a href="https://www.apple.com/newsroom/2019/04/qualcomm-and-apple-agree-to-drop-all-litigation/">settled</a> in April 2019. 
What&#8217;s Next: Analysts predict the companies will eventually settle, probably with Qualcomm paying more to access Arm's tech. 
The proceedings are anticipated to conclude by Friday, Dec. 20.
It&#8217;s worth noting that the chips in question power most mainstream devices, and the legal dispute could have wide-ranging repercussions on the tech industry. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42514661/snowflakes-ai-glow-up-golden-cross-signals-flash-as-analysts-aim-high">Snowflake AI Revolution Gains Traction, Stock Forms Golden Cross</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

Legal

ETFs

QCOM

SEMI

SOXL

SOXQ

Arm, Qualcomm Face Off In Court: What To Expect From Silicon Soap Opera

CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) has outperformed the market over the past 10 years by 5.58% on an annualized basis producing an average annual return of 16.89%. Currently, CACI International has a market capitalization of $9.34 billion. 
Buying $100 In CACI: If an investor had bought $100 of CACI stock 10 years ago, it would be worth $478.76 today based on a price of $416.95 for CACI at the time of writing.
<h3>CACI International's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734389108_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CACI

Here's How Much $100 Invested In CACI International 10 Years Ago Would Be Worth Today

JBDI

JBDI Holdings Receives Delinquency Notification Letter From Listing Qualifications Department Of Nasdaq

Reviva intends to use the net proceeds from the offering to fund research and development activities and for working capital and other general corporate purposes.
&nbsp;

Offerings

RVPH

Reviva  Proposes To Offer And Sell Shares Of Its Common Stock And Warrants In Public Offering; No Terms Disclosed

The lots are being recalled due to failures of the blood circuit associated with too many mismatch alarms.&nbsp; The blood circuits may indicate "Ultrafiltrate Weight Mismatch" or "Excessive Weight Mismatch" alarms while in use.&nbsp; If not addressed, this failure could result in excess fluid removal from a patient leading to Acute Volume Depletion.&nbsp;&nbsp;
As of the date of this Current Report on Form 8-K, the Company is aware of five reported incidences of blood circuit product failures, with three leading to patient dehydration and requiring administration of fluids.&nbsp;
The recall is being conducted with the knowledge of the U.S. Food and Drug Administration which has not yet characterized the Class of the recall.

NUWE

On December 11, 2024, Nuwellis Sent A Notice To Affected Customers That It Is Voluntarily Recalling Specific Lots Of AquaFlexFlow UF 500 Plus Extracorporeal Blood Circuit Which Is Used With The Aquadex Smartflow Or Aquadex Flexflow System - Filing

Affirm Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) shares are trading lower in Monday&#8217;s after-hours session after the Buy Now, Pay Later company announced a <a href="https://www.benzinga.com/pressreleases/24/12/b42517777/affirm-holdings-inc-announces-proposed-private-offering-of-750-million-of-convertible-senior-notes">proposed private offering</a>.
What Happened: After the market close on Monday, Affirm announced plans to offer $750 million worth of convertible senior notes due 2029 in a private offering to institutional buyers. The company will also grant the initial purchasers a 13-day option to buy up to an additional $112.5 million of the notes. 
Affirm plans to use the net proceeds to repurchase some of its&nbsp;0%&nbsp;convertible senior notes due 2026. In addition, the company will use a portion of the net proceeds combined with cash on hand to repurchase up to $300 million of its common stock at a price equal to Affirm&#8217;s closing price on the date of the pricing of the notes. 
The offering comes just days after Affirm announced a <a href="https://www.benzinga.com/tech/24/12/42486903/affirm-secures-4-billion-loan-deal-with-sixth-street-to-boost-bnpl-growth">long-term capital partnership</a> with investment firm Sixth Street in which it will invest up to $4 billion through the purchase of Affirm loans. The transaction provides additional off-balance sheet funding with the ability for Affirm to extend up to more than $20 billion in loans over the next three years.
As of the end of September, Affirm had $2.1 billion in total liquidity split between cash and securities available for sale. The company also had $1.2 billion remaining in convertible debt, down from $1.3 billion at the end of the prior quarter.
AFRM Price Action: <a href="http://benzinga.com/quote/afrm">Affirm shares</a> were down 2.28% in after-hours, trading at $71.20 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
See Also: • <a href="https://www.benzinga.com/news/global/24/12/42513807/trump-says-softbanks-100b-commitment-to-us-is-monumental-demonstration-of-confidence-in-americas-future">Trump Says SoftBank&#8217;s $100B Commitment To US Is &#8216;Monumental Demonstration Of Confidence In America&#8217;s Future&#8217;</a>
Photo: Courtesy of Affirm.

Buybacks

After-Hours Center

AFRM

Affirm Holdings Stock Is Moving Lower After Hours: Here's Why

Stocks with improving and deteriorating 'TechniGrade' by Piper Sandler

BMO Capital initiated coverage of Nurix Therapeutics (NRIX) with an Outperform rating and $35 price target The firm believes the company is poised ...

Nurix Therapeutics initiated with an Outperform at BMO Capital

Management reviews new data from the Company's Phase 1 Clinical Trial of BTK Degrader NX-5948 on a conference call to be held on December 9 at 11 p...

Nurix Therapeutics holds a pharmaceutical update conference call

Analyst Gil Blum from Needham reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) and keeping the price target at $29.00. Gil Bl...

Optimistic Buy Rating for Nurix Therapeutics' NX-5948 Driven by Strong Efficacy in CLL and Strategic Expansion Plans

The latest announcement is out from Nurix Therapeutics ( ($NRIX) ). Nurix Therapeutics unveiled promising data from its Phase 1a/1b trial of NX-594...

Nurix Therapeutics Reports Promising Trial Results for NX-5948

Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report) today and set a price target of $34.0...

Nurix Therapeutics (NRIX) Receives a Buy from Stifel Nicolaus

In a report released today, Matthew Biegler from Oppenheimer maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report), with a price t...

Oppenheimer Reaffirms Their Buy Rating on Nurix Therapeutics (NRIX)

Barclays analyst Peter Lawson assigned a Buy rating to Nurix Therapeutics (NRIX – Research Report) today and set a price target of $31.00. The comp...

Nurix Therapeutics (NRIX) Receives a Buy from Barclays

In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report), with a pric...

Nurix Therapeutics (NRIX) Gets a Buy from Piper Sandler

Tracking Baker Brothers Portfolio - Q3 2024 Update

ABCL

ACAD

ACCD

ALGS

ALKS

AMRX

APPF

ARGNF

ARGX

AVDX

AVGO

AVTE

BCYC

BEIGF

BGNE

BMBL

BMEA

BOWL

CERS

CHGG

DECK

DNLI

ESTC

EWTX

FIVN

GLUE

HOOK

HSIC

IGMS

IMCR

IMTX

INCY

INSM

JNPR

KALA

KNSA

KRMD

KYMR

MDGL

MKTX

NBHC

NRIX

OSCR

RARE

REPL

ROKU

RSKD

RVMD

RYTM

SDGR

SGMT

SMMT

STOK

TCRX

TRDA

TSVT

VTVT

Press Releases

Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur

Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom's Macroglobulinemia

Health Care

Nurix Therapeutics Announces Presentations at the 7th Annual TPD & Induced Proximity Summit

Nurix Therapeutics to Participate in Upcoming Investor Conferences

Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting

Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024

Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia

Nurix Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nurix Therapeutics Announces Webcast To Review New Data from Its Phase 1 Clinical Trial of BTK Degrader NX-5948 Presented at the 66th American Society of Hematology (ASH) Annual Meeting

Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting

Ardelyx

Arcutis Biotherapeutics, Inc. - Common stock

Arcutis Biotherapeutics

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

CareDx

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies

Galapagos NV - American Depositary Shares

Galapagos

Immunocore Holdings plc - American Depositary Shares

Immunocore Hldgs

Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares

Kiniksa Pharmaceuticals

MiMedx Group

Mesoblast Limited - American Depositary Shares

Mesoblast

Comments

Nurix Therapeutics

Interés en corto

Nurix Therapeutics (NASDAQ:NRIX) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL